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Background: Staphylococcus is a leading cause of nosocomial
and community acquired infections. The discovery of penicillins
made the treatment of such infections possible. The widespread
and improper use of these agents made them practically useless
as bacteria developed resistance to their action, a fact that created
the need for newer agents. Moxiﬂoxacin (MOX), a fourth genera-
tion ﬂuoroquinolone, is one such agent currently recommended for
treating staphylococcal infections, including methicillin-resistant
ones. In this study, we explored the effectiveness of MOX, alone
and in combination with benzalkonium chloride (BZ), in treating
methicillin-resistant staphylococcal ocular isolates obtained from
pediatric outpatients in two hospitals in Alexandria, Egypt.We also
studied the rate and magnitude of resistance development as a
result of MOX use.
Methods & Materials:We determined theminimum inhibitory
concentrations (MICs) of MOX and other antibiotics against the
tested isolates, using the agar dilution technique. For laboratory
induction ofMOX resistance,we serially passed the susceptible iso-
lates in medium containing increasing concentrations of MOX. We
used time kill assays to assess the combination of sub-inhibitory
concentrations of MOX and BZ against selected isolates.
Results: A total of 107 methicillin resistant staphylococcal
ocular isolates were collected from patients suffering from con-
junctivitis (n=75) or blepharitis (n=32). Moxiﬂoxacin resistance
was detected in 48.6% of the isolates. Of the MOX-susceptible
isolates, 71.43% were resistant to oﬂoxacin, ciproﬂoxacin and lev-
oﬂoxacin. Upon laboratory induction of MOX resistance in a subset
of the MOX-susceptible isolates, seven of the 15 (46.67%) MOX-
susceptible isolates developed MOX resistance with 2 to 16-fold
increases in MIC. The combination of MOX and BZ (a commonly
used preservative in eye drops, but surprisingly not used in MOX
preparations) resulted in a bactericidal synergistic combination
with large reductions in survivors relative to control (>6 logs) and
MOX (∼2 logs) alone.
Conclusion: Compared to older ﬂuoroquinolone members,
MOX showed greater therapeutic potential and fewer resistance
levels. However, the continued use of MOX is expected to trigger
higher resistance rates. Therefore, and on the basis of their syn-
ergy, we recommend the use of BZ as a preservative in MOX eye
drop preparations to retard resistance development.
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Emergence, spread and exchange of blaNDM-1
gene among Enterobacteriaceae in septicaemic
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Background: Treatment of neonatal sepsis has become a chal-
lengewith theemergenceof carbapenemase-producingbacteria. In
recent years, the proliferation of New Delhi Metallo--lactamases
has changed the scenario signiﬁcantly. NDM is a zinc–requiring
MBL that can hydrolyse all penicillins, cephalosporins, carbapen-
ems and spares only the monobactam aztreonam. NDM-1 is often
associated with other antibiotic resistance genes and plasmids car-
rying blaNDM-1 can easily transfer this resistance to other bacteria.
Current worldwide dissemination of the blaNDM-1 was not related
to the spread of one ormore speciﬁc clones, to the spread of speciﬁc
plasmids, or to the dissemination of one given genetic cassette.
Methods & Materials: The trend of carbapenem resistance
in our unit was studied over ﬁve year period (2007-2011). All
Enterobacteriaceae isolatedwere identiﬁedandantibiotic suscepti-
bility proﬁle was evaluated along with phenotypic tests. Molecular
typing and conjugation/transformation was performed only for
carbapenemase-producing isolates. Further molecular character-
ization and genetic features including plasmid-typing, presence of
insertion-sequences and analysis of integron-structures were car-
ried out for carbapenem-resistant Enterobacteriaceae.
Results: FifteenNDM-1-harbouring Enterobacteriaceae isolates
were identiﬁed from blood of septicaemic neonates; no other
carbapenemases were identiﬁed. NDM-1 producing isolates were
resistant to other broad-spectrum antibiotics and possessed ESBLs,
AmpCs, 16S-rRNA methylases, AAC(6’)-Ib-cr and class 1 integron.
Pulsed ﬁeld gel electrophoresis indicated that the isolates were
clonally diverse (Figure 1); hence, conjugal transfer of blaNDM-1 was
investigated. NDM-1 was harboured by different plasmid scaffolds
(FIA/FIB, L/M, FIIs, R, N, FIIK, HIB-M/FIB-M and nontypable) which
were successfully transferred to E. coli J53 strain. Genetic structures
Figure 1. Analysis of the genetic relationship according to Dice’s similarity coefﬁ-
cient and the unweighted pair group method with arithmetic mean (UPGMA) (the
position tolerance and optimization were set at 1.0 and 1.0% respectively) of the
XbaI patte.
